Media Contact:
Ihor Andruch
CPRi Communications
201-641-1911 x50
iandruch@cpronline.com

FOR IMMEDIATE RELEASE

SEPTEMBER IS NATIONAL CHOLESTEROL EDUCATION MONTH:
TEAFLAVIN® IS NATURAL, GREEN TEA EXTRACT WITH DOCUMENTED HUMAN CLINICAL
TRIALS TO LOWER LDL-CHOLESTEROL

Study Published in Archives of Internal Medicine Documents Effectiveness of an Enriched
Tea Extract to Lower LDL-C by 16.4 Percent with No Adverse Effects.

Nashville, Tenn. - September 15, 2004 - For millions of Americans bordering on dangerously high cholesterol, learning the value of a healthy diet and exercise coupled with the natural cholesterol-lowering effect of Teaflavin® (www.nashai.com) - the first tea extract with clinical trials in humans to show a cholesterol-lowering effect from tea - may be one of the most important lessons learned during September, National Cholesterol Education Month.

In July, 2004 U.S. health officials issued new guidelines recommending people at very high risk of heart attack - such as cigarette smokers, those with existing cardiovascular disease, or poorly controlled high blood pressure - lower their LDL to less than 70 milligrams per deciliter, from the previous goal of 100. The guidelines also recommended drug therapy for high-risk individuals with LDL levels of 100 or higher.

"While studies show that cholesterol-lowering Rx statin medications are extremely effective, there's also solid scientific evidence that Teaflavin®, the all natural, caffeine-free product now available to consumers as a 375 milligram daily capsule, not only lowers LDL-C by 16.4 percent but also raises HDL - good cholesterol - by 3-4 percent," says Jim Zhao, Ph.D., a molecular biologist and Chief Science Officer, Nashai Biotech, LLC. "The idea is to do everything natural first."

According to the American Heart Association, people with total cholesterol of 240 and above have double the risk of heart disease as those who keep their cholesterol under 200. The study published in Archives of Internal Medicine (6/23/03) showed one reason why people who consume large amounts of green tea have a lower risk of heart disease. Developed by Nashai Biotech, LLC, Teaflavin®, the concentrated tea extract, offers a practical way to get the benefits of tea without side effects, because one dose delivers the benefits of 35 cups of green tea.

The double-blind, randomized, placebo-controlled, parallel-group trial involved 240 men and women age 18 or older on a low fat diet, with baseline LDL-C (bad cholesterol) between 130-190. After 12 weeks, those who received a 375 milligram daily capsule containing the tea extract lowered their LDL-C by 16.4 percent and raised HDL - good cholesterol - by 3-4 percent. Teaflavin® represents the highest concentration of tea flavonoids on the market today.

"Since there are few people who can or will drink that amount of tea, Teaflavin® is a safe, non-pharmacologic and cost-effective option - a first-line therapy for maintaining healthy cholesterol levels," concludes Zhao.

For ordering information call 800-876-4332 (U.S. orders only).

About Nashai Biotech, LLC
Headquartered in Nashville, Tennessee with offices in Irvine, California and Shanghai, China, Nashai Biotech, LLC (www.nashai.com) produces patented, new generation formulas and ingredients based upon compelling scientific evidence. Nashai's flagship product is Teaflavin®.

###